Your browser doesn't support javascript.
loading
Long runs of homozygosity are associated with Alzheimer's disease.
Moreno-Grau, Sonia; Fernández, Maria Victoria; de Rojas, Itziar; Garcia-González, Pablo; Hernández, Isabel; Farias, Fabiana; Budde, John P; Quintela, Inés; Madrid, Laura; González-Pérez, Antonio; Montrreal, Laura; Alarcón-Martín, Emilio; Alegret, Montserrat; Maroñas, Olalla; Pineda, Juan Antonio; Macías, Juan; Marquié, Marta; Valero, Sergi; Benaque, Alba; Clarimón, Jordi; Bullido, Maria Jesus; García-Ribas, Guillermo; Pástor, Pau; Sánchez-Juan, Pascual; Álvarez, Victoria; Piñol-Ripoll, Gerard; García-Alberca, Jose María; Royo, José Luis; Franco-Macías, Emilio; Mir, Pablo; Calero, Miguel; Medina, Miguel; Rábano, Alberto; Ávila, Jesús; Antúnez, Carmen; Real, Luis Miguel; Orellana, Adelina; Carracedo, Ángel; Sáez, María Eugenia; Tárraga, Lluís; Boada, Mercè; Cruchaga, Carlos; Ruiz, Agustín.
Affiliation
  • Moreno-Grau S; Research Center and Memory clinic Fundació ACE. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Fernández MV; CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain.
  • de Rojas I; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Garcia-González P; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Hernández I; Research Center and Memory clinic Fundació ACE. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Farias F; CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain.
  • Budde JP; Research Center and Memory clinic Fundació ACE. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Quintela I; Research Center and Memory clinic Fundació ACE. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Madrid L; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States of America.
  • González-Pérez A; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Montrreal L; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Alarcón-Martín E; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Alegret M; Grupo de Medicina Xenómica, Centro Nacional de Genotipado (CEGEN-PRB3-ISCIII), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Maroñas O; CAEBI. Centro Andaluz de Estudios Bioinformáticos, Sevilla, Spain.
  • Pineda JA; CAEBI. Centro Andaluz de Estudios Bioinformáticos, Sevilla, Spain.
  • Macías J; Research Center and Memory clinic Fundació ACE. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Marquié M; Grupo de Medicina Xenómica, Centro Nacional de Genotipado (CEGEN-PRB3-ISCIII), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Valero S; Unidad Clínica de Enfermedades Infecciosas y Microbiología. Hospital Universitario de Valme, Sevilla, Spain.
  • Benaque A; Unidad Clínica de Enfermedades Infecciosas y Microbiología. Hospital Universitario de Valme, Sevilla, Spain.
  • García-Ribas G; Research Center and Memory clinic Fundació ACE. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Pástor P; CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain.
  • Sánchez-Juan P; Research Center and Memory clinic Fundació ACE. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.
  • Álvarez V; CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain.
  • Piñol-Ripoll G; Research Center and Memory clinic Fundació ACE. Institut Català de Neurociències Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.
  • García-Alberca JM; CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain.
  • Royo JL; Memory Unit, Neurology Department and Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Franco-Macías E; CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain.
  • Mir P; Centro de Biología Molecular Severo Ochoa (C.S.I.C.-U.A.M.), Universidad Autónoma de Madrid, Madrid, Spain.
  • Calero M; Instituto de Investigación Sanitaria "Hospital la Paz" (IdIPaz), Madrid, Spain.
  • Medina M; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Rábano A; Fundació per la Recerca Biomèdica i Social Mútua Terrassa, and Memory Disorders Unit, Department of Neurology, Hospital Universitari Mútua de Terrassa, University of Barcelona School of Medicine, Terrassa, Barcelona, Spain.
  • Ávila J; CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain.
  • Antúnez C; Neurology Service "Marqués de Valdecilla" University Hospital (University of Cantabria and IDIVAL), Santander, Spain.
  • Real LM; Laboratorio de Genética Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Orellana A; Instituto de Investigación Biosanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
  • Carracedo Á; CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain.
  • Sáez ME; Unitat Trastorns Cognitius, Hospital Universitari Santa Maria de Lleida, Institut de Recerca Biomédica de Lleida (IRBLLeida), Lleida, Spain.
  • Tárraga L; Alzheimer Research Center & Memory Clinic, Andalusian Institute for Neuroscience, Málaga, Spain.
  • Boada M; Dep. of Surgery, Biochemistry and Molecular Biology, School of Medicine, University of Málaga, Málaga, Spain.
  • Cruchaga C; Unidad de Demencias, Servicio de Neurología y Neurofisiología. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Ruiz A; CIBERNED, Center for Networked Biomedical Research on Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain.
Transl Psychiatry ; 11(1): 142, 2021 02 24.
Article in En | MEDLINE | ID: mdl-33627629
Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and recessive inheritance. The presence of recessive loci is suggested for Alzheimer's disease (AD); however, their search has been poorly assessed to date. To investigate homozygosity in AD, here we performed a fine-scale ROH analysis using 10 independent cohorts of European ancestry (11,919 AD cases and 9181 controls.) We detected an increase of homozygosity in AD cases compared to controls [ßAVROH (CI 95%) = 0.070 (0.037-0.104); P = 3.91 × 10-5; ßFROH (CI95%) = 0.043 (0.009-0.076); P = 0.013]. ROHs increasing the risk of AD (OR > 1) were significantly overrepresented compared to ROHs increasing protection (p < 2.20 × 10-16). A significant ROH association with AD risk was detected upstream the HS3ST1 locus (chr4:11,189,482‒11,305,456), (ß (CI 95%) = 1.09 (0.48 ‒ 1.48), p value = 9.03 × 10-4), previously related to AD. Next, to search for recessive candidate variants in ROHs, we constructed a homozygosity map of inbred AD cases extracted from an outbred population and explored ROH regions in whole-exome sequencing data (N = 1449). We detected a candidate marker, rs117458494, mapped in the SPON1 locus, which has been previously associated with amyloid metabolism. Here, we provide a research framework to look for recessive variants in AD using outbred populations. Our results showed that AD cases have enriched homozygosity, suggesting that recessive effects may explain a proportion of AD heritability.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Alzheimer Disease Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Alzheimer Disease Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2021 Type: Article